SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-026826
Filing Date
2018-11-05
Accepted
2018-11-05 16:06:36
Documents
58
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aldr-10q_20180930.htm 10-Q 2127492
2 EX-10.1 aldr-ex101_167.htm EX-10.1 10690
3 EX-31.1 aldr-ex311_11.htm EX-31.1 15514
4 EX-31.2 aldr-ex312_12.htm EX-31.2 15551
5 EX-32.1 aldr-ex321_7.htm EX-32.1 8661
  Complete submission text file 0001564590-18-026826.txt   6490905

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aldr-20180930.xml EX-101.INS 1246032
7 XBRL TAXONOMY EXTENSION SCHEMA aldr-20180930.xsd EX-101.SCH 48083
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldr-20180930_cal.xml EX-101.CAL 54309
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldr-20180930_def.xml EX-101.DEF 162193
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldr-20180930_lab.xml EX-101.LAB 342993
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldr-20180930_pre.xml EX-101.PRE 271769
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Filer) CIK: 0001423824 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36431 | Film No.: 181159934
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences